Chiara Tommasi
About Chiara Tommasi
Chiara Tommasi is a Senior Manager MSL Immunology at Bristol Myers Squibb in Rome, Italy, with extensive experience in disease area specialization and medical science management.
Company
Chiara Tommasi is currently employed at Bristol Myers Squibb. She holds the position of Senior Manager MSL Immunology in Rome, Latium, Italy. Since 2014, she has taken on various roles within the company, focusing on disease area specialization in fields such as cardiovascular health, HIV, and now immunology.
Title
Chiara Tommasi serves as the Senior Manager MSL Immunology at Bristol Myers Squibb. Her role involves managing medical science liaisons and leading the company's immunology efforts in Rome, Latium, Italy.
Education and Expertise
Chiara Tommasi studied at the University of Rome 'Tor Vergata,' where she specialized in Infectious and Tropical Diseases from 2003 to 2007. She achieved her degree in Medicine and Surgeons from Libera Università 'Campus Bio-Medico,' Roma, where she studied from 1997 to 2003. Additionally, she earned a Master's degree in Clinical Pharmacology of antiretroviral drugs from Università degli Studi di Torino. Her extensive educational background complements her hands-on experience in clinical and basic research on HIV/AIDS, with an emphasis on the clinical pharmacology of antiretrovirals.
Background
Chiara Tommasi's professional journey began as an M.D. at the National Institute for Infectious Diseases, a position she held from 2007 to 2014. She transitioned to Bristol Myers Squibb in 2014, initially serving as a Medical Science Manager in Virology. Over the years, she has held multiple roles including Disease Area Specialist in both HIV and Cardiovascular lines. Since 2021, she has been focused on immunology, advancing to her current role as Senior Manager MSL Immunology.
Achievements
Throughout her career, Chiara Tommasi has been involved in pioneering research on HIV/AIDS, specifically concentrating on the clinical pharmacology of antiretrovirals. She also has a specialization in cardiovascular diseases, which has informed her various roles at Bristol Myers Squibb. Her comprehensive work and transition across multiple disease areas showcase her versatility and expertise in the pharmaceutical and clinical research fields.